Cargando…

Clinical field trial of parenteral amoxicillin for the treatment of clinical and subclinical mastitis in smallholder dairy farms in the upper region of Northern Thailand

BACKGROUND AND AIM: Mastitis, primarily caused by intramammary bacterial infection, is the most expensive disease in the global dairy industry due to its negative impact on milk composition and manufacturing properties. This study aimed to evaluate the efficacy of parenteral amoxicillin in the treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Pangprasit, Noppason, Srithanasuwan, Anyaphat, Intanon, Montira, Suriyasathaporn, Witaya, Chaisri, Wasana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Veterinary World 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206963/
https://www.ncbi.nlm.nih.gov/pubmed/37235160
http://dx.doi.org/10.14202/vetworld.2023.792-798
_version_ 1785046343001047040
author Pangprasit, Noppason
Srithanasuwan, Anyaphat
Intanon, Montira
Suriyasathaporn, Witaya
Chaisri, Wasana
author_facet Pangprasit, Noppason
Srithanasuwan, Anyaphat
Intanon, Montira
Suriyasathaporn, Witaya
Chaisri, Wasana
author_sort Pangprasit, Noppason
collection PubMed
description BACKGROUND AND AIM: Mastitis, primarily caused by intramammary bacterial infection, is the most expensive disease in the global dairy industry due to its negative impact on milk composition and manufacturing properties. This study aimed to evaluate the efficacy of parenteral amoxicillin in the treatment of clinical and subclinical mastitis in smallholder dairy farms in Northern Thailand. MATERIALS AND METHODS: A total of 51 cows with clinical and subclinical mastitis from dairy cooperatives in Lamphun and Chiang Mai provinces, Northern Thailand, were enrolled in this study. Conventional bacteriological procedures were applied to identify the causative bacteria in milk samples from these cows before and 7 days after treatment, and antibiotic susceptibility tests were conducted using the disk diffusion method for all bacteria isolated before treatment. All cows with mastitis were administered 15 mg/kg of amoxicillin (LONGAMOX(®), Syva Laboratories SA, Spain) intramuscularly every other day for 3 days. RESULTS: Environmental streptococcal bacteria (Streptococcus uberis and Streptococcus spp.) were commonly isolated from infected quarters and were highly susceptible to amoxicillin (100%). The clinical efficacy of amoxicillin treatment for clinical mastitis cases was 80.43%, and the bacteriological efficacy was 47.82%, with opportunistic staphylococcal bacteria (coagulase-negative staphylococci) and contagious streptococcal bacteria (Streptococcus agalactiae) being the most sensitive microorganisms (100%). In subclinical mastitis cases, the bacteriological efficacy of parenteral amoxicillin was 70.45%, with environmental streptococcal bacteria (S. uberis) being the most (100%) sensitive microorganisms. CONCLUSION: Amoxicillin is highly efficacious and can be used to treat clinical and subclinical mastitis in dairy cows, particularly mastitis caused by environmental Streptococcus spp. These findings could be used to guide treatment regimens in veterinary practice in smallholder dairy farms in Thailand.
format Online
Article
Text
id pubmed-10206963
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Veterinary World
record_format MEDLINE/PubMed
spelling pubmed-102069632023-05-25 Clinical field trial of parenteral amoxicillin for the treatment of clinical and subclinical mastitis in smallholder dairy farms in the upper region of Northern Thailand Pangprasit, Noppason Srithanasuwan, Anyaphat Intanon, Montira Suriyasathaporn, Witaya Chaisri, Wasana Vet World Research Article BACKGROUND AND AIM: Mastitis, primarily caused by intramammary bacterial infection, is the most expensive disease in the global dairy industry due to its negative impact on milk composition and manufacturing properties. This study aimed to evaluate the efficacy of parenteral amoxicillin in the treatment of clinical and subclinical mastitis in smallholder dairy farms in Northern Thailand. MATERIALS AND METHODS: A total of 51 cows with clinical and subclinical mastitis from dairy cooperatives in Lamphun and Chiang Mai provinces, Northern Thailand, were enrolled in this study. Conventional bacteriological procedures were applied to identify the causative bacteria in milk samples from these cows before and 7 days after treatment, and antibiotic susceptibility tests were conducted using the disk diffusion method for all bacteria isolated before treatment. All cows with mastitis were administered 15 mg/kg of amoxicillin (LONGAMOX(®), Syva Laboratories SA, Spain) intramuscularly every other day for 3 days. RESULTS: Environmental streptococcal bacteria (Streptococcus uberis and Streptococcus spp.) were commonly isolated from infected quarters and were highly susceptible to amoxicillin (100%). The clinical efficacy of amoxicillin treatment for clinical mastitis cases was 80.43%, and the bacteriological efficacy was 47.82%, with opportunistic staphylococcal bacteria (coagulase-negative staphylococci) and contagious streptococcal bacteria (Streptococcus agalactiae) being the most sensitive microorganisms (100%). In subclinical mastitis cases, the bacteriological efficacy of parenteral amoxicillin was 70.45%, with environmental streptococcal bacteria (S. uberis) being the most (100%) sensitive microorganisms. CONCLUSION: Amoxicillin is highly efficacious and can be used to treat clinical and subclinical mastitis in dairy cows, particularly mastitis caused by environmental Streptococcus spp. These findings could be used to guide treatment regimens in veterinary practice in smallholder dairy farms in Thailand. Veterinary World 2023-04 2023-04-19 /pmc/articles/PMC10206963/ /pubmed/37235160 http://dx.doi.org/10.14202/vetworld.2023.792-798 Text en Copyright: © Pangprasit, et al. https://creativecommons.org/licenses/by/4.0/Open Access. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Pangprasit, Noppason
Srithanasuwan, Anyaphat
Intanon, Montira
Suriyasathaporn, Witaya
Chaisri, Wasana
Clinical field trial of parenteral amoxicillin for the treatment of clinical and subclinical mastitis in smallholder dairy farms in the upper region of Northern Thailand
title Clinical field trial of parenteral amoxicillin for the treatment of clinical and subclinical mastitis in smallholder dairy farms in the upper region of Northern Thailand
title_full Clinical field trial of parenteral amoxicillin for the treatment of clinical and subclinical mastitis in smallholder dairy farms in the upper region of Northern Thailand
title_fullStr Clinical field trial of parenteral amoxicillin for the treatment of clinical and subclinical mastitis in smallholder dairy farms in the upper region of Northern Thailand
title_full_unstemmed Clinical field trial of parenteral amoxicillin for the treatment of clinical and subclinical mastitis in smallholder dairy farms in the upper region of Northern Thailand
title_short Clinical field trial of parenteral amoxicillin for the treatment of clinical and subclinical mastitis in smallholder dairy farms in the upper region of Northern Thailand
title_sort clinical field trial of parenteral amoxicillin for the treatment of clinical and subclinical mastitis in smallholder dairy farms in the upper region of northern thailand
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206963/
https://www.ncbi.nlm.nih.gov/pubmed/37235160
http://dx.doi.org/10.14202/vetworld.2023.792-798
work_keys_str_mv AT pangprasitnoppason clinicalfieldtrialofparenteralamoxicillinforthetreatmentofclinicalandsubclinicalmastitisinsmallholderdairyfarmsintheupperregionofnorthernthailand
AT srithanasuwananyaphat clinicalfieldtrialofparenteralamoxicillinforthetreatmentofclinicalandsubclinicalmastitisinsmallholderdairyfarmsintheupperregionofnorthernthailand
AT intanonmontira clinicalfieldtrialofparenteralamoxicillinforthetreatmentofclinicalandsubclinicalmastitisinsmallholderdairyfarmsintheupperregionofnorthernthailand
AT suriyasathapornwitaya clinicalfieldtrialofparenteralamoxicillinforthetreatmentofclinicalandsubclinicalmastitisinsmallholderdairyfarmsintheupperregionofnorthernthailand
AT chaisriwasana clinicalfieldtrialofparenteralamoxicillinforthetreatmentofclinicalandsubclinicalmastitisinsmallholderdairyfarmsintheupperregionofnorthernthailand